Innovative Eyewear gets Nasdaq bid-price notice; has until April 7, 2027 to regain $1.00

Innovative Eyewear Inc

• Received Oct. 9, 2026 notice from Nasdaq Listing Qualifications Staff; LUCY common stock closed below $1.00 for 30 consecutive business days, breaching Rule 5550(a)(2).
• Notice has no immediate effect on listing; 180-day cure period runs to April 7, 2027, requiring a $1.00+ closing bid for at least 10 straight business days.
• If uncured, company may qualify for a second 180-day period if it meets initial Nasdaq Capital Market criteria and signals intent to do a reverse stock split if needed.
• Failure to cure could trigger a delisting notice; Innovative Eyewear could appeal to the Nasdaq Hearings Panel, which would stay suspension pending the hearing.
• Company says it will monitor its closing bid price and consider all options to regain compliance, with no assurance it will succeed.